{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:15:16Z","timestamp":1789942516862,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2013CB733701"],"award-info":[{"award-number":["2013CB733701"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Program of National Natural Science Foundation of China","award":["81230013"],"award-info":[{"award-number":["81230013"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170484"],"award-info":[{"award-number":["81170484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation (CN)","doi-asserted-by":"publisher","award":["7122199"],"award-info":[{"award-number":["7122199"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20130001110079"],"award-info":[{"award-number":["20130001110079"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2300-7","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:08:32Z","timestamp":1460621312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"16","author":[{"given":"Qiu-Mei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Rui","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"key":"2300_CR1","doi-asserted-by":"crossref","unstructured":"Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006:133\u201341","DOI":"10.1182\/asheducation-2006.1.133"},{"key":"2300_CR2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3324\/haematol.2012.080432","volume":"98","author":"S Chiaretti","year":"2013","unstructured":"Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica. 2013;98:1702\u201310.","journal-title":"Haematologica"},{"key":"2300_CR3","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia(ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007;109:3189\u201397.","journal-title":"Blood"},{"key":"2300_CR4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000360204","volume":"132","author":"PW Burke","year":"2014","unstructured":"Burke PW, Douer D. Acute lymphoblastic leukemia in adolescents and young adults. Acta Haematol. 2014;132:264\u201373.","journal-title":"Acta Haematol"},{"key":"2300_CR5","doi-asserted-by":"crossref","unstructured":"Lazarus HM, Luger S. Which patients with adult acute lymphoblastic leukemia should undergo a hematopoietic stem cell transplantation? Case-Based Discussion. Hematology Am Soc Hematol Educ Program. 2007:444\u201352","DOI":"10.1182\/asheducation-2007.1.444"},{"key":"2300_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/leu.2014.242","volume":"29","author":"RB Walter","year":"2015","unstructured":"Walter RB, Othus M, Burnett AK, L\u00f6wenberg B, Kantarjian HM, Ossenkoppele GJ, et al. Resistance prediction in AML: analysis of 4601 patients from MRC\/NCRI, HOVON\/SAKK, SWOG and MD Anderson Cancer Center. Leukemia. 2015;29:312\u201320.","journal-title":"Leukemia"},{"key":"2300_CR7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758\u201364.","journal-title":"Nature"},{"key":"2300_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110\u20134.","journal-title":"Nature"},{"key":"2300_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4331\/wjbc.v2.i6.105","volume":"2","author":"S Dovat","year":"2011","unstructured":"Dovat S. Ikaros in hematopoiesis and leukemia. World J Biol Chem. 2011;2:105\u20137.","journal-title":"World J Biol Chem"},{"key":"2300_CR10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","volume":"114","author":"I Iacobucci","year":"2009","unstructured":"Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood. 2009;114:2159\u201367.","journal-title":"Blood"},{"key":"2300_CR11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/pbc.24571","volume":"60","author":"Y Yamashita","year":"2013","unstructured":"Yamashita Y, Shimada A, Yamada T, Yamaji K, Hori T, Tsurusawa M, et al. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:1587\u201392.","journal-title":"Pediatr Blood Cancer"},{"key":"2300_CR12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","volume":"24","author":"RP Kuiper","year":"2010","unstructured":"Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B, et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia. 2010;24:1258\u201364.","journal-title":"Leukemia"},{"key":"2300_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470\u201380.","journal-title":"N Engl J Med"},{"key":"2300_CR14","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","volume":"122","author":"A Veer Van der","year":"2013","unstructured":"Van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, et al. Independent prognostic value of BCRABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood. 2013;122:2622\u20139.","journal-title":"Blood"},{"key":"2300_CR15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3324\/haematol.2012.075432","volume":"98","author":"C Palmi","year":"2013","unstructured":"Palmi C, Valsecchi MG, Longinotti G, Silvestri D, Carrino V, Conter V, et al. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? Haematologica. 2013;98:1226\u201331.","journal-title":"Haematologica"},{"key":"2300_CR16","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","volume":"27","author":"G Martinelli","year":"2009","unstructured":"Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP Report. J Clin Oncol. 2009;27:5202\u20137.","journal-title":"J Clin Oncol"},{"key":"2300_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/ejh.12155","volume":"91","author":"K Tokunaga","year":"2013","unstructured":"Tokunaga K, Yamaguchi S, Iwanaga E, Nanri T, Shimomura T, Suzushima H, et al. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia. Eur J Haematol. 2013;91:201\u20138.","journal-title":"Eur J Haematol"},{"key":"2300_CR18","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","volume":"123","author":"K Beldjord","year":"2014","unstructured":"Beldjord K, Chevret S, Asnafi V, Huguet F, Boulland ML, Leguay T, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123:3739\u201349.","journal-title":"Blood"},{"key":"2300_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.critrevonc.2003.11.003","volume":"50","author":"R Bassan","year":"2004","unstructured":"Bassan R, Gatta G, Tondini C, Willemze R. Adult acute lymphoblastic leukaemia. Crit Rev Oncol Hematol. 2004;50:223\u201361.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2300_CR20","first-page":"454","volume":"15","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, He Q, Huang XJ, Jiang H, Yang SM, Lu J, et al. Cytogenetic study on eosinophilia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15:454\u20137.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2300_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1751-553X.2007.00962.x","volume":"30","author":"YZ Qin","year":"2008","unstructured":"Qin YZ, Liu YR, Zhu HH, Li JL, Ruan GR, Zhang Y, et al. Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response. Internatl Lab Hematol. 2008;30:317\u201323.","journal-title":"Internatl Lab Hematol"},{"key":"2300_CR22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) \u2013 a Europe against cancer program. Leukemia. 2003;17:2474\u201386.","journal-title":"Leukemia"},{"key":"2300_CR23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2012.073965","volume":"98","author":"A Caye","year":"2013","unstructured":"Caye A, Beldjord K, Mass-Malo K, Drunat S, Soulier J, Gandemer V, et al. Breakpoint-specific multiplex PCR allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2013;98:597\u2013601.","journal-title":"Haematologica"},{"key":"2300_CR24","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbmt.2014.04.011","volume":"20","author":"CH Yan","year":"2014","unstructured":"Yan CH, Jiang Q, Wang J, Xu LP, Liu DH, Jiang H, et al. Superior Survival of Unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant. 2014;20:1314\u201321.","journal-title":"Bone Marrow Transplant"},{"key":"2300_CR25","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"DP Lu","year":"2006","unstructured":"Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including anti thymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107:3065\u201373.","journal-title":"Blood"},{"key":"2300_CR26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbmt.2008.11.025","volume":"15","author":"XJ Huang","year":"2009","unstructured":"Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Treatment of acute leukemia with unmanipulated HLA-mismatched\/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant. 2009;15:257\u201365.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2300_CR27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2013-06-509794","volume":"123","author":"A Veer Van der","year":"2014","unstructured":"Van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, et al. IKZF1 status as a prognostic feature in BCR-ABL1\u2013positive childhood ALL. Blood. 2014;123:1691\u20138.","journal-title":"Blood"},{"key":"2300_CR28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/CBM-140425","volume":"14","author":"M Jia","year":"2014","unstructured":"Jia M, Wang ZJ, Li JY, Yang SL, Zhao HZ, Cheng YP, et al. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis. Cancer Biomarkers. 2014;14:493\u2013503.","journal-title":"Cancer Biomarkers"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2300-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:37:11Z","timestamp":1589654231000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2300-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2300-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,11]]},"article-number":"269"}}